Viewing Study NCT00535028


Ignite Creation Date: 2025-12-26 @ 10:34 AM
Ignite Modification Date: 2026-02-28 @ 9:11 PM
Study NCT ID: NCT00535028
Status: COMPLETED
Last Update Posted: 2007-09-26
First Post: 2007-09-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study)
Sponsor: Aerovance, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module